Rawi Hazzan

944 total citations
17 papers, 316 citations indexed

About

Rawi Hazzan is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Rawi Hazzan has authored 17 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Rawi Hazzan's work include Hepatitis B Virus Studies (6 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Rawi Hazzan is often cited by papers focused on Hepatitis B Virus Studies (6 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Rawi Hazzan collaborates with scholars based in Israel, United States and Germany. Rawi Hazzan's co-authors include Leonard Leibovici, Jihad Bishara, Zmira Samra, Elad Goldberg, Mical Paul, Hila Shaked, Galia Kariv, Isaac Yaniv, Hannah Tamary and Joanne Yacobovich and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Rawi Hazzan

14 papers receiving 311 citations

Peers

Rawi Hazzan

EPIDE

PHEOH

AMB

Noa Zemer‐Wassercug Israel

Sanjay Biswas India

G. A. Klyasova Russia

Mickaël Aoun Belgium

Theo Zaoutis United States

Nour Abidi Belgium

Rashidkhan Pathan Switzerland

Mar Marín Spain

Nicholas Britt United States

Julia Origüen Spain

Noa Zemer‐Wassercug Israel

Rawi Hazzan

133 ×0.8

80 ×0.6

101 ×1.1

EPIDE

48 ×0.8

PHEOH

10 ×0.3

AMB

Citations per year, relative to Rawi Hazzan Rawi Hazzan (= 1×) peers Noa Zemer‐Wassercug

Countries citing papers authored by Rawi Hazzan

Since Specialization

Citations

This map shows the geographic impact of Rawi Hazzan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rawi Hazzan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rawi Hazzan more than expected).

Fields of papers citing papers by Rawi Hazzan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rawi Hazzan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rawi Hazzan. The network helps show where Rawi Hazzan may publish in the future.

Co-authorship network of co-authors of Rawi Hazzan

This figure shows the co-authorship network connecting the top 25 collaborators of Rawi Hazzan. A scholar is included among the top collaborators of Rawi Hazzan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rawi Hazzan. Rawi Hazzan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Haimi, Motti, et al.. (2025). Reduced Predictive Performance of the FIB‐4 Index in Chronic Hepatitis B Patients With Concurrent Metabolic Dysfunction‐Associated Liver Disease. Journal of Viral Hepatitis. 32(10). e70071–e70071.

Hazzan, Rawi, et al.. (2025). Ultrasound Shear Wave Elastography and Shear Wave Dispersion: Correlation with Histopathological Changes in Autoimmune Hepatitis Patients. Ultrasound in Medicine & Biology. 51(5). 823–829. 1 indexed citations

Baker, Fadi Abu, et al.. (2025). Advancements in autoimmune hepatitis epidemiology, treatment and complication – a 15-year retrospective study. Clinics and Research in Hepatology and Gastroenterology. 49(4). 102570–102570. 1 indexed citations

Neeman, Ziv, et al.. (2024). Increased Risk of Non-Hodgkin Lymphoma in Autoimmune Hepatitis: A Large Retrospective Cohort Study. Journal of Clinical Medicine. 13(20). 6258–6258.

Abu‐Freha, Naim, et al.. (2024). Sex Differences in Colonoscopy Indications and Findings: Results from a Large Multicenter Database. Journal of Women s Health. 33(11). 1442–1448.

Neumann, Helmut, Haim Shirin, Lior H. Katz, et al.. (2024). A computer-aided polyp detection system in screening and surveillance colonoscopy: an international, multicentre, randomised, tandem trial. The Lancet Digital Health. 6(3). e157–e165. 13 indexed citations

Neumann, Helmut, Haim Shirin, Lior H. Katz, et al.. (2023). 744 A NOVEL COMPUTER-AIDED POLYP DETECTION SYSTEM IN DAILY CLINICAL CARE: AN INTERNATIONAL MULTICENTER, RANDOMIZED, TANDEM TRIAL. Gastroenterology. 164(6). S–152. 1 indexed citations

Benson, Ariel A., Harold Jacob, Lior H. Katz, et al.. (2022). ARTIFICIAL INTELLIGENCE (AI) BASED REAL-TIME AUTOMATIC POLYP SIZE ESTIMATION DURING COLONOSCOPY. Gastrointestinal Endoscopy. 95(6). AB251–AB251. 1 indexed citations

Hazzan, Rawi, et al.. (2021). Association of proton pump inhibitor use with the development of febrile neutropenia in lymphoma patients. Expert Review of Hematology. 14(5). 503–507. 3 indexed citations

10.

Sakran, Nasser, Ahmad Assalia, Ziv Neeman, et al.. (2020). The use of Ursolit for gallstone prophylaxis following bariatric surgery: a randomized-controlled trial. Updates in Surgery. 72(4). 1125–1133. 20 indexed citations

11.

Hazzan, Rawi, et al.. (2019). Twelve Weeks Treatment with Ombitasvir/Paritaprevir/ Ritonavir and Dasabuvir in Chronic Hepatitis C Genotype 2k/1b Patients is Highly Efficient and Safe. 3(1). 1 indexed citations

12.

Welzel, Tania M., Stefan Zeuzem, Emily O. Dumas, et al.. (2016). GARNET: High SVR Rates Following Eight-Week Treatment with Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir for Patients with HCV Genotype 1b Infection. The American Journal of Gastroenterology. 111. S388–S388. 1 indexed citations

13.

Mansur, Nariman, Rawi Hazzan, Mical Paul, Jihad Bishara, & Leonard Leibovici. (2012). Does Sex Affect 30-Day Mortality in Staphylococcus Aureus Bacteremia?. Gender Medicine. 9(6). 463–470. 24 indexed citations

14.

Paul, Mical, Galia Kariv, Elad Goldberg, et al.. (2010). Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. Journal of Antimicrobial Chemotherapy. 65(12). 2658–2665. 169 indexed citations

15.

Goldberg, Elad, M. Paul, Zmira Samra, et al.. (2010). Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study. Journal of Antimicrobial Chemotherapy. 65(8). 1779–1783. 42 indexed citations

16.

Hazzan, Rawi, Mical Paul, Hila Shaked, et al.. (2007). R2180 Effect of adequate empiric antibiotic therapy on survival of patients with methicillin-resistant Staphylococcus aureus bacteraemia. International Journal of Antimicrobial Agents. 29. S631–S631. 1 indexed citations

17.

Hazzan, Rawi, et al.. (2006). Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura. Pediatric Blood & Cancer. 47(S5). 657–659. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact